PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Mar-2022 Non Fusion Spinal Devices Market is expected to increase at a CAGR of 4.8 percent from 2022 to 2026 MARKITWIRED
01-Mar-2022 Citicoline Market Is Projected To Grow At 8.5% CAGR Through 2028 MARKITWIRED Latest Market Reports
01-Mar-2022 Vocal Biomarkers Worth Of US$ 390 Mn Are Envisaged To Be Sold Across The Globe By 2027 MARKITWIRED Latest Market Reports
01-Mar-2022 Arthroscopy Devices Market s expected to record a CAGR of 7.1% to reach a valuation of US$ 5.61 Billion by 2022 MARKITWIRED
01-Mar-2022 Global Antibiotic Residue Test Kits Market Is Expected To Witness Growth At 6.2% CAGR In Terms Of Value By The End Of 2026 MARKITWIRED Latest Market Reports
01-Mar-2022 Cardiovascular Enterprise Viewer Market s drive by the rapid technological advancement, increase in the involvement information technology in healthcare industry MARKITWIRED
01-Mar-2022 Melanoma Cancer Diagnostics Market Is Expected To Register CAGR Of 4.7% By 2028 MARKITWIRED Latest Market Reports
01-Mar-2022 Orthopedic Power Tools Market growing at a CAGR of 3.9% over the forecast period MARKITWIRED
01-Mar-2022 Diagnostic X-Ray System Market will reach a valuation of US$ 16.86 Billion by 2028 MARKITWIRED
01-Mar-2022 Nephrology and Urology Incontinence Devices Market is expected to grow at a healthy CAGR in the forecasted period MARKITWIRED
01-Mar-2022 Radiology Information System RIS Market is projected to register a CAGR of 7.6% during the forecast period MARKITWIRED
01-Mar-2022 Biochemicals Control Market progressing at a CAGR of 12.7% during the forecast Period MARKITWIRED
01-Mar-2022 Surgical Sutures Market is likely to attain a CAGR of 5.4% during the forecast period MARKITWIRED
01-Mar-2022 Computed Tomography Market to Witness Stunning Growth by 2025 MARKITWIRED
01-Mar-2022 Knee Replacement Market Market Revenue Growth Predicted by 2025 MARKITWIRED
01-Mar-2022 CARVYKTI™ (ciltacabtagene autoleucel), BCMA-Directed CAR-T Therapy, Receives U.S. FDA Approval for the Treatment of Adult Patients With Relapsed or Refractory Multiple Myeloma Businesswire
01-Mar-2022 La FDA accepte la demande d'autorisation de mise sur le marché de produit biologique (Biologics License Application, BLA) d'Alvotech pour la substituabilité de l'Humira® par ATV02, un candidat biosimilaire haute concentration sans citrate Businesswire
01-Mar-2022 FDA nimmt BLA-Antrag von Alvotech an, der die Austauschbarkeit von ATV02 unterstützt, einem hochkonzentrierten, zitratfreien Biosimilar-Kandidaten für Humira® Businesswire
01-Mar-2022 extractX Ltd. Announces Financial Results for the First Quarter of 2022 Businesswire
28-Feb-2022 Medical Display Market 2022 : Size, Share, Trends, Growth, Strategies, Opportunities, Top Companies, Regional Analysis and Forecast to 2029 The Wire Times